References
1. Brachman
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1522900/
2. The Department of Defense Anthrax Vaccine Immunization Program: Unproven Force Protection Fourth Report by the Committee on Government Reform
https://www.govinfo.gov/content/pkg/CRPT-106hrpt556/html/CRPT-106hrpt556.htm
3. Research Advisory Committee on Gulf War Veterans' Illnesses Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations Washington, D.C.: U.S. Government Printing Office, November 2008
https://www.va.gov/RAC-GWVI/docs/Committee_Documents/GWIandHealthofGWVeterans_RAC-GWVIReport_2008.pdf
4. Clarifying Guidance for the Smallpox and Anthrax Vaccination Programs
https://www.centcom.mil/AREA-OF-RESPONSIBILITY/
5. VAERS database
​
https://vaers.hhs.gov/
6. What is a Serious Adverse Event?
https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event
7. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Rosenthal S1, Chen R. 1995.
http://www.ncbi.nlm.nih.gov/pubmed/7503351
8. Electronic Support for Public Health-Vaccine Adverse Event Reporting System
https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
9. Is the US's Vaccine Adverse Event Reporting System broken?
https://www.bmj.com/content/383/bmj.p2582
10. Clinical Policy for the Administration of Anthrax Vaccine Adsorbed July 31st 2009
https://health.mil/Reference-Center/Policies/2009/07/31/Clinical-Policy-for-the-Administration-of-the-Anthrax-Vaccine-Adsorbed
11. U.S. General Accounting Office. Anthrax Vaccine: GAO's Survey of Guard and Reserve Pilots and Aircrew. Washington, D.C. Sep, 2002.
https://www.gao.gov/assets/gao-02-445.pdf
12. The Anthrax Vaccine: Is It Safe? Does It Work? (2002)
https://nap.nationalacademies.org/catalog/10310/the-anthrax-vaccine-is-it-safe-does-it-work
13. Gulf War and Health: Volume 1. Depleted Uranium, Sarin, Pyridostigmine Bromide, and Vaccines
http://iom.nationalacademies.org/Reports/2000/Gulf-War-and-Health-Vol-1-Depleted-Uranium-Sarin-Pyridostigmine-Bromide-and-Vaccines.aspx
14. DoD Faces Challenges in implementing its Anthrax Vaccine Immunisation Program
https://www.gao.gov/products/NSIAD-00-36
15. GAO: Military Health: DOD's Vaccine Healthcare Centers Network 29th June 2007.
http://www.gao.gov/new.items/d07787r.pdf
16. https://www.health.mil/Military-Health-Topics/Health-Readiness/AFHSD/Data-Management-and-Technical-Support/Defense-Medical-Surveillance-System
17. The Defense Medical Surveillance System and the Department of Defense Serum Repository: Glimpses of the Future of Public Health Surveillance Rubertone M 2002
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447349/
18. U.S. Barred From Forcing Troops to Get Anthrax Shots
https://www.washingtonpost.com/archive/politics/2004/10/28/us-barred-from-forcing-troops-to-get-anthrax-shots/563b1195-3fdd-475c-808f-53428137bfc8/
19. US soldiers refuse to fall in line with anthrax vaccination scheme
https://www.nature.com/articles/nm0204-112b
20. Comprehensive systematic surveillance for adverse effects of Anthrax Vaccine Adsorbed, US Armed Forces, 1998–2000Jeffrey L. Lange et al. 2003
https://pubmed.ncbi.nlm.nih.gov/12639483/
21. CDC Anthrax Vaccine Safety and Efficacy Research program
https://www.nap.edu/read/10527/chapter/1
22. Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed. Payne et al. 2007.
http://www.ncbi.nlm.nih.gov/pubmed/16444796
23. Detailed Safety Review of Anthrax Vaccine Adsorbed January 2015 Compiled by the Immunization Healthcare Branch Defense Health Agency, Falls Church, Virginia
https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Anthrax/Anthrax-Resource-Center
24. Risk of disability for US army personnel vaccinated against anthrax, 1998-2005.
Sulsky et al. 2011
https://www.ncbi.nlm.nih.gov/pubmed/21704102
25. Disability among US Army Veterans vaccinated against anthrax. Sulsky et al. 2012.
https://www.ncbi.nlm.nih.gov/pubmed/22874851/
26. Package insert
https://www.fda.gov/media/71954/download
27. https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Anthrax
28. Getting Rich on Uncle Sucker Should the Federal Government Strengthen Efforts to Fight Profiteering? Scott Lilly October 2010
https://www.americanprogress.org/wp-content/uploads/issues/2010/10/pdf/unclesucker_execsumm.pdf
29. Company Led by Top Admiral Buys Michigan Vaccine Lab
https://www.nytimes.com/1998/07/08/us/company-led-by-top-admiral-buys-michigan-vaccine-lab.html
30. Emergent Biosolutions / Bioport Board of Directors: How to Sell to the US Government. Nass, M
http://anthraxvaccine.blogspot.com/2007/06/emergent-biosolutionsbioport-board-of.html
31. Emergent Biosolutions Awarded BARDA Contract for Advanced Development and Delivery of Nuthrax a Next Generation Antrhax Vaccine, Valued at up to $1.6 Billion.
https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-awarded-barda-contract-advanced
32. Data show a difference in incidence of local reactions between lots of Anthrax vaccine: short-term safety experience in humans Pittman P 2001
https://pubmed.ncbi.nlm.nih.gov/11738765/
33. Encl. 18: Microscopy video, pin prick blood from Th1 chronically ill patients.
http://www.autoimmunityresearch.org/lax2006.ram
34. Bacterial persistence and expression of disease. Domingue et al. 1997.
https://www.ncbi.nlm.nih.gov/pubmed/9105757
35. Demystifying pleomorphic forms in persistence and expression of disease: Are they bacteria, and is peptidoglycan the solution? Domingue. 2010
https://www.ncbi.nlm.nih.gov/pubmed/20875345
36. Cell Wall-deficient Bacteria as a Cause of Infections: a Review of the Clinical Significance. Onwuamaegbu et el. 2005.
https://www.ncbi.nlm.nih.gov/pubmed/15651712
37. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes. Proal et al. 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28245427
38. New insights into bacterial persistence in reactive arthritis. Astraukiene et al. 2007.
https://www.ncbi.nlm.nih.gov/pubmed/17631749
39. L-form bacteria cohabitants in human blood: significance for health and diseases.
Markova. 2017.
https://www.ncbi.nlm.nih.gov/pubmed/28715646
40. Differential transcriptional response in macrophages infected with cell wall deficient versus normal Mycobacterium Tuberculosis. Fu et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25552926
41. Interaction of alveolar macrophages with Staphylococcus aureus and induction of microbial L-forms during infection in rats. Michailova et al. 2000.
https://www.ncbi.nlm.nih.gov/pubmed/10959728
42. Atypical behaviour and survival of Streptococcus pyogenes L forms during intraperitoneal infection in rats. Michailova et al. 2000.
https://www.ncbi.nlm.nih.gov/pubmed/10767608
43. Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma. Ou et al. 2014.
https://www.ncbi.nlm.nih.gov/pubmed/24589592
44. Cell-wall-deficient bacteria: a major etiological factor for psoriasis? Wang et al. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/20137493
45. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Amar et al. 2011.
https://www.ncbi.nlm.nih.gov/pubmed/2197614
46. How bacterial pathogens colonize their hosts and invade deeper tissues.
Ribet et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25637951
47. New Insights into Bacterial Persistence in Reactive Arthritis Astrauskiene et al. 2007
https://pubmed.ncbi.nlm.nih.gov/17631749/
48. The Dormant Blood Micribiome in Chronic Inflammatory Illnesses Poteieter et el. 2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487407/
49. Filterable forms and L-forms of Mycobacterium bovis BCG: impact for live vaccine features. Markova et a. 2012.
https://www.ncbi.nlm.nih.gov/pubmed/22495116
50. Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination.
Markova et al. 2015.
https://www.ncbi.nlm.nih.gov/pubmed/25874947
51. Inflammatory disease and the human microbiome. Proal et al. 2014.
https://www.ncbi.nlm.nih.gov/pubmed/24882717
52. Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis. Proal et al. 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23576059
53. The human microbiome and autoimmunity. Proal et al. 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23370376
54. Immunostimulation in the era of the metagenome. Proal et al. 2011.
https://www.ncbi.nlm.nih.gov/pubmed/21278764
55. Autoimmune disease in the era of the metagenome. Proal et al. 2009.
https://www.ncbi.nlm.nih.gov/pubmed/19393196
56. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Marshall TG et al. 2006.
https://www.ncbi.nlm.nih.gov/pubmed/16403216
57. https://health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Recommendations/Vaccine-Recommendations-by-AOR
58. Children’s Health Defense
https://childrenshealthdefense.org/defender/welcome-to-the-defender/
59. Informed Consent Action Network
https://icandecide.org/
60. Prevalence and patterns of Gulf War Illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Steele L. 2000
https://pubmed.ncbi.nlm.nih.gov/11092441/
61. Health and exposures of United Kingdom Gulf War Veterans, II: the relation of health to exposure. Cherry N, et al. 2001
Part 1 https://oem.bmj.com/content/58/5/291
Part 2 https://oem.bmj.com/content/58/5/299
62. Health of UK servicemen who served in Persian Gulf War. Unwin C, et al. 1999.
https://pubmed.ncbi.nlm.nih.gov/9923871/
63. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. Hotoph M, et al. 2000.
https://pubmed.ncbi.nlm.nih.gov/10818024/
64. Reanalysis of Gulf War vaccination data does not contradict
findings. Hotoph M. 2000
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1127872/
65. Anthrax vaccination and self-reported symptoms, functional status and medical conditions inthe national health survey of Gulf War era veterans and their families Mahan CM et al. 2004
https://pubmed.ncbi.nlm.nih.gov/15018879/
66. Increased symptom reporting was associated with several exposures, including having more than 10 immunisations, Kelsall et al. 2004
https://pubmed.ncbi.nlm.nih.gov/15550607/
67. CDC children’s vaccines
https://www.cdc.gov/vaccines/vpd/vaccines-age.html
68. 72 Vaccine Doses and No Placebo Trials
https://icandecide.org/72-vaccine-doses-no-placebo-trials/
69. Data and Statistics on Children’s Mental Health
https://www.cdc.gov/childrensmentalhealth/data.html
70. Gupta RS, Warren CM, Smith BM, Blumenstock JA, Jiang J, Davis MM, Nadeau KC. The public health impact of parent-reported childhood food allergies in the united states. Pediatrics. 2018;142(6):e20181235.
https://pubmed.ncbi.nlm.nih.gov/30455345/
71. A National and State Profile of Leading Health Problems and Health Care Quality for US Children: Key Insurance Disparities and Across-State Variations Bethell, C 2011
https://www.academicpedsjnl.net/article/S1876-2859(10)00250-0/fulltext
72. Dynamics of obesity and chronic health conditions among children and youth cleave 2010.
https://pubmed.ncbi.nlm.nih.gov/20159870/
73. Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders Hooker, B. et al.2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268563/
74. Health effects in vaccinated versus unvaccinated children, with covariates for breastfeeding status and type of birth HookerB. et al. 2021
https://www.oatext.com/pdf/JTS-7-459.pdf
75. Lyons Weiler Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination Lyons-Weiler J. et al. 2020
https://pubmed.ncbi.nlm.nih.gov/33266457/
76. Retraction: Lyons-Weiler, J.; Thomas, P. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination. Int. J. Environ. Res. Public Health 2020, 17, 8674
https://pubmed.ncbi.nlm.nih.gov/34360528/
77. Correction: Lyons-Weiler, J., et al. Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses along the Axis of Vaccination. Int. J. Environ. Res. Public Health 2020, 17, 8674 James Lyons-Weiler 1 , Paul Thomas
https://pubmed.ncbi.nlm.nih.gov/33499430/
78. Revisiting Excess Diagnoses of Illnesses and Conditions in Children Whose Parents Provided Informed Permission to Vaccinate Them James Lyons-Weiler ET AL.2022
https://www.researchgate.net/publication/363882194_Revisiting_Excess_Diagnoses_of_Illnesses_and_Conditions_in_Children_Whose_Parents_Provided_Informed_Permission_to_Vaccinate_Them
79. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children Mawson A. et al. 2017
https://www.oatext.com/pdf/JTS-3-186.pdf
80. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children Anthony R Mawson 2017
https://www.oatext.com/pdf/JTS-3-187.pdf
81. The relationship between vaccination and self report of atopic disease in children Enriquez R. Et al. 2005
https://pubmed.ncbi.nlm.nih.gov/15805992/
82. Vax-Unvax: Let the Science Speak (Children’s Health Defense)
https://mitpressbookstore.mit.edu/book/9781510766969
83. Lotter V. Epidemiology of autistic conditions in young children 1966
https://link.springer.com/article/10.1007/BF00584048
84. https://www.cdc.gov/ncbddd/autism/data.html
85. Autism and Deveopmental Disabilities Monitoring Network 2023
https://www.cdc.gov/ncbddd/autism/pdf/ADDM-Community-Report-SY2020-h.pdf
86. Prevalence of Autism (including Asperger Syndrome) in School Age Children in Northern Ireland Annual Report 2023
https://www.health-ni.gov.uk/sites/default/files/publications/health/asd-children-ni-2023.pdf
87. The proportion of minimally verbal children with autism spectrum disorder in a community-based early intervention programme. Rose V. 2016
https://pubmed.ncbi.nlm.nih.gov/27120989/
88. National Autistic Society New shocking data highlights the autism employment gap
https://www.autism.org.uk/what-we-do/news/new-data-on-the-autism-employment-gap
89. emergence of asd in simplex families: relations to parental perceptions on etiology
Goin Kochel R. 2015
https://pubmed.ncbi.nlm.nih.gov/25398603/
90. parental perceptions and use of complementary and alternative medicine practices for children with asd in private practice harrington J. 2006
https://pubmed.ncbi.nlm.nih.gov/16685182/
91. https://www.cdc.gov/vaccinesafety/concerns/autism.html
92. Adverse Effects of Vaccines Evidence and Causlity
https://nap.nationalacademies.org/catalog/13164/adverse-effects-of-vaccines-evidence-and-causality
93. Does Vaccination Increase the Risk of Autism Spectrum Disorder? Mohammed et al. 2022.
https://pubmed.ncbi.nlm.nih.gov/36110492/
94. Vaccine Safety: Myths and Misinformation Geoghegan et al. 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090020/
95. The myth of vaccination and autism spectrum Gabis et al. 2021.
https://pubmed.ncbi.nlm.nih.gov/34996019/
96. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies Taylor L. et al. 2014
https://pubmed.ncbi.nlm.nih.gov/24814559/
97. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults Fraiman J. et al. 2022
https://pubmed.ncbi.nlm.nih.gov/36055877/
98. FDA oversight of clinical trials is “grossly inadequate,” say experts.
https://www.bmj.com/content/379/bmj.o2628
99. React 19 group
https://react19.org/science
100. Excess deaths in 2023 Campbell, J.
https://www.youtube.com/watch?v=nJ0QL7EwJp4
101. https://www.militaryaccountability.com/
102. Industry reduced early-stage research, favoring medical devices, bioengineered drugs, and late-stage clinical trials Moses, H. 2015
https://pubmed.ncbi.nlm.nih.gov/25585329/
103. Trial sans Error: How Pharma-Funded Research Cherry-Picks Positive Results
https://www.scientificamerican.com/article/trial-sans-error-how-pharma-funded-research-cherry-picks-positive-results/
104. The Impact of Industry Funding on Randomized Controlled Trials of Biologic Therapies Gazendam,1. et al. 2022
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951352/
105. How pharmaceutical industry funding affects trial outcomes: Causal structures and responses? Author links open overlay panel Sergio Sismondo 2008
https://www.sciencedirect.com/science/article/abs/pii/S0277953608000361
106. Cochrane Industry sponsorship and research outcome
https://www.cochrane.org/MR000033/METHOD_industry-sponsorship-and-research-outcome
107. Industry Funding of Clinical Trials: Benefit or Bias? Sameer S. Chopra, AM
https://jamanetwork.com/journals/jama/fullarticle/196846
108. Evidence-based medicine has been hijacked: a report to David Sackett 2003
https://www.jclinepi.com/article/S0895-4356%2816%2900147-5/abstract?cc=y=
://fas.org/sgp/crs/misc/R43341.pdf
109. Scientific American: How drug company money is undermining science.
https://www.scientificamerican.com/article/how-drug-company-money-undermining-science/
110. Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science Sismondo, S. 2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028448/
111. Cochrane Industry sponsorship and research outcome
https://pubmed.ncbi.nlm.nih.gov/23235689/
112. The decline of science at the FDA has become unmanageable Ross B 2023
https://www.bmj.com/content/381/bmj.p1061
113. https://vaxxedthemovie.com/stream/
114. https://www.merck.com/news/dr-julie-l-gerberding-to-retire-from-merck/
115. https://www.merck.com/news/merck-announces-appointment-of-dr-julie-gerberding-as-executive-vice-president-for-strategic-communications-global-public-policy-and-population-health/
116. Improving medical research in the United Kingdom Stephen H. Bradley, Nicholas J. DeVito, Kelly E. Lloyd, Patricia Logullo & Jessica E. Butler 2022
https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-022-06050-y
117. https://www.britannica.com/biography/Ignaz-Semmelweis
118. Suppressing Scientific Discourse on Vaccines? Self-perceptions of researchers and practitioners Elisha E 2022
https://pubmed.ncbi.nlm.nih.gov/35587319/
119. Emergent BioSolutions to Support HHS Anthrax Preparedness Strategy With Up to $1 Billion in BioThrax Deliveries to the Strategic National Stockpile
​
​
120. Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
​
https://www.sec.gov/Archives/edgar/data/1367644/000136764423000199/a11282023cyfendus.htm
​
121. Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
​
122. Statistica
​
https://www.statista.com/topics/1719/pharmaceutical-industry/#topicOverview
​
123. Possible role of L-form switching in recurrent urinary tract infection. Mickiewicz et al. 2019
​
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763468/
​
124. Repurposing Drugs with Specific Activity Against L-Form Bacteria. Emami et al. 2023
​
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110866/pdf/fmicb-14-1097413.pdf
​
125. Trends in Allergic Conditions Among Children: United States, 1997–2011. Jackson et al. 2013.
​
https://www.cdc.gov/nchs/products/databriefs/db121.htm
​
​